December 19, 2024

FDA Rejects New Bowel Disease Drug

The FDA declined to approve Zealand Pharma's bowel disease drug and sought an additional trial to confirm the drug's safety and efficacy, impacting thousands of adult patients in the United States.

Reuters

December 17, 2024

Teva Sanofi Drug Hits IBD Trial Goals

"These unprecedented results show that duvakitug could represent the next frontier in treating ulcerative colitis and Crohn’s disease."

Reuters

December 17, 2024

Food Recall Trends: Listeria, Salmonella, and E. coli Risks

Explore key insights from a 2-decade analysis of US food recalls, revealing alarming trends in foodborne illness outbreaks caused by Listeria, Salmonella, and E. coli, and the need for improved food safety measures.

Conexiant

December 16, 2024

Probiotics' Limits Revealed in Major Review

"Current evidence does not support the notion that probiotics can restore the microbiota to its pre-antibiotic state."

Conexiant

December 16, 2024

Migraine Medicine May Help Gut Disorders

A genetic analysis published in Neurology Genetics revealed significant shared genetic connections between migraine and various gastrointestinal disorders, suggesting avenues for targeted treatment through the CGRP pathway.

Conexiant

December 11, 2024

Colectomy Raises AKI, Kidney Failure Risk in IBD

A recent study has revealed that patients with inflammatory bowel disease face elevated risks of acute kidney injury and chronic kidney failure after undergoing colectomy, with certain factors increasing these risks. Read more about the study in Clinical Gastroenterology and Hepatology.

Conexiant

December 11, 2024

Study Identifies Viable H. pylori in Root Canals of Infected Teeth

New study finds viable Helicobacter pylori in oral cavity root canals of endodontically infected primary teeth in children, potentially posing a risk for reinfection or transmission. Published in Cell Communication and Signaling.

Conexiant

December 06, 2024

Endometriosis Pain: Two Key Phenotypes Identified

A recent study identified two distinct pain phenotypes in patients with endometriosis, revealing significant differences in symptom severity, comorbidities, and quality of life.

Conexiant

December 05, 2024

Affordable Blue Dye Method Measures Gut Transit Time

A recent study unveiled the potential of a novel blue dye method for measuring gut transit time and its associations with microbiome composition and cardiometabolic health, offering a low-cost and scalable alternative to traditional measures.

Conexiant